Delivery Order SPE2DR25D1201-SPE2DR26FAKBE
- Not listed
- The Defense Logistics Agency awarded a $3,269.01 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on October 24, 2025, with completion targeted for October 27, 2025. This competitively awarded, firm fixed-price contract is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $10,493.06 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.08 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $13,310.20 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on December 2, 2025, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $17,574.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $9,656.92 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3 ml quantities. The contract represents a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) with a ceiling value of $3,607.20. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,759.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on August 25, 2025, with an ultimate completion date of August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a $3,838.06 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on December 4, 2025, with completion due by December 5, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $6,095.49 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performs at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKBEDelivery Order
The Defense Logistics Agency awarded a $12,046.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's federal contracts consistently demonstrate its capability to fulfill open competition procurement requirements and serve multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support military operations and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 12/8/25 |